The diagnosis of hepatobiliary and gastrointestinal issues can be challenging without a clear understanding of their pathogenesis. Pain in the abdominal region may be identified as a symptom of pregnancy, an adverse effect of certain drugs, or a psychosomatic issue. However, it is necessary to consider the possibility of cholecystitis, hepatitis, gastritis, and other gastrointestinal diseases, depending on the localization and circumstances. The presented case is a perfect example of a scenario in which appropriate diagnosis and treatment depend on external factors that must be analyzed.
The patient in this case presents with various symptoms suggesting a gastrointestinal problem. A possible diagnosis is acute cholecystitis, supported by several findings from the anamnesis and prior medical history. This disease may be caused by duct obstruction, leading to reduced bile excretion (MedlinePlus, 2023). This issue leads to increased pressure and irritation, which causes the RUQ pain described in the problem. Moreover, the preceding large dinner is a factor that stimulates bile secretion and exertion, increasing the risk of blockage and cholecystitis (Jones et al., 2023).
The AST level is also close to the upper limit of normal, which may suggest a hepatobiliary issue, even though other laboratory tests show no abnormalities. Female sex, diabetes, and age are also risk factors for the suggested disease. Conversely, other presented options like pregnancy, drugs, or psychological disorders are less applicable.
The medical history of BCPs and pain localization decreases the chances of pregnancy, and the listed medications do not have adverse effects that could manifest similarly to expressed symptoms. Psychological conditions also lack evidence in the presented evaluation. Therefore, acute cholecystitis is the most probable diagnosis for this patient.
An appropriate treatment strategy must address pain, nausea, fluid balance, possible infections, and thrombosis risks. Pain management may start with 1g of Paracetamol and Diclofenac with subsequent 5mg Morphine if needed (Jones et al., 2023). Nausea can be treated with 50mg of Cyclizine to stop water loss.
To control fluids more effectively, 0.9% intravenous Saline can be prescribed. Based on the described allergies, 400mg of Ciprofloxacin via IV is the preferred infection preventive measure. The risk of thrombosis noted in the medical history must be managed with Enoxaparin at a daily dose of 40mg. This set of medications will be the most efficient and safe for the patient. In conclusion, the case involves a female with acute cholecystitis who needs a combination of preventive and therapeutic measures to address the disease.
References
Jones, M. W., Genova, R., & O’Rourke, M. C. (2023). Acute Cholecystitis. StatPearls Publishing.
MedlinePlus. (2023). Acute cholecystitis.